Ghent University Academic Bibliography

Your filters: cql: author="Neven, Patrick" or (type any "bookEditor issueEditor" and editor="Neven, Patrick")

Add to list
- Journal Article
Camizestrant, a next-generation oral SERD, versus fulvestrant in post-menopausal women with oestrogen receptor-positive, HER2-negative advanced breast cancer (SERENA-2): a multi-dose, open-label, randomised, phase 2 trial

Mafalda Oliveira, Denys Pominchuk, Zbigniew Nowecki, Erika Hamilton, Yaroslav Kulyaba, Timur Andabekov, Yevhen Hotko, Tamar Melkadze, Gia Nemsadze, Patrick Neven, et al.

(2024) The Lancet Oncology. 25(11). p.1424-1439
Add to list
- Journal Article
- A1
Cognitions and physical impairments in relation to upper limb function in women with pain and myofascial dysfunctions in the late stage after breast cancer surgery : an exploratory cross-sectional study

Liesbet De Baets, Nele Devoogdt, Vincent Haenen, Margaux Evenepoel (UGent) , Lore Dams, Ann Smeets, Patrick Neven, Inge Geraerts, Tessa De Vrieze and An De Groef

(2022) DISABILITY AND REHABILITATION. 44(18). p.5212-5219
Add to list
- Journal Article
- A1
Randomized CLIO/BGOG-ov10 trial of olaparib monotherapy versus physician's choice chemotherapy in relapsed ovarian cancer

Adriaan Vanderstichele, Liselore Loverix, Pieter Busschaert, Els Van Nieuwenhuysen, Sileny N. Han, Nicole Concin, Tiene Callewaert, Siel Olbrecht, Rawand Salihi (UGent) , Patrick Berteloot, et al.

(2022) GYNECOLOGIC ONCOLOGY. 165(1). p.14-22
Add to list
PIK3CA in breast cancer : a Belgian practical testing guideline

Glenn Broeckx, Aline Hébrant, Nicky D'Haene, Koen Van de Vijver (UGent) , Jacques Van Huysse, Isabelle Vanden Bempt, Philippe Aftimos, Patrick Neven and Patrick Pauwels

(2021) BELGIAN JOURNAL OF MEDICAL ONCOLOGY. 15(6). p.304-314
Add to list
- Journal Article
- A1
Radical hysterectomy without adjuvant radiotherapy in patients with cervix carcinoma FIGO 2009 IB1, with or without positive Sedlis criteria

Jolien Haesen, Rawand Salihi (UGent) , Toon Van Gorp, Els Van Nieuwenhuysen, Sileny N. Han, Melissa Christiaens, Anne-Sophie Van Rompuy, Lise Waumans, Patrick Neven and Ignace Vergote

(2021) GYNECOLOGIC ONCOLOGY. 162(3). p.539-545
Add to list
- Journal Article
- A1
- open access
The mitotic checkpoint is a targetable vulnerability of carboplatin-resistant triple negative breast cancers

Stijn Moens, Peihua Zhao, Maria Francesca Baietti, Oliviero Marinelli, Delphi Van Haver (UGent) , Francis Impens (UGent) , Giuseppe Floris, Elisabetta Marangoni, Patrick Neven, Daniela Annibali, et al.

(2021) SCIENTIFIC REPORTS. 11.
Add to list
- Conference Paper
- C3
Adherence to and patient satisfaction with the combination therapy of exemestane and everolimus in postmenopausal women with HR+ HER2- advanced breast cancer : results from the IPSOC-mamma study

Veerle Foulon, Carrie Visser, Sandra De Coster, Lise-Marie Kinnaer (UGent) , Ellen Reynders, Anne Deblander, Patrick Berteloot, Kevin Punie, Hans Wildiers, Veronique Cocquyt (UGent) , et al.

(2021) CANCER RESEARCH. In Cancer Research 81(4, Supplement S).
Add to list
- Journal Article
- A1
- open access
Cancer surveillance in healthy carriers of germline pathogenic variants in BRCA1/2 : a review of secondary prevention guidelines

Boudewijn Dullens, Robin de Putter (UGent) , Matteo Lambertini, Angela Toss, Sileny Han, Els Van Nieuwenhuysen, Toon Van Gorp, Adriaan Vanderstichele, Chantal Van Ongeval, Machteld Keupers, et al.

(2020) JOURNAL OF ONCOLOGY. 2020.
Add to list
Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

Haoyu Zhang, Thomas U. Ahearn, Julie Lecarpentier, Daniel Barnes, Jonathan Beesley, Guanghao Qi, Xia Jiang, Tracy A. O’Mara, Ni Zhao, Manjeet K. Bolla, et al.

(2020) NATURE GENETICS. 52(6). p.572-581
Add to list
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

Laura Fachal, Hugues Aschard, Jonathan Beesley, Daniel R. Barnes, Jamie Allen, Siddhartha Kar, Karen A. Pooley, Joe Dennis, Kyriaki Michailidou, Constance Turman, et al.

(2020) NATURE GENETICS. 52(1).

Academic Bibliography

Camizestrant, a next-generation oral SERD, versus fulvestrant in post-menopausal women with oestrogen receptor-positive, HER2-negative advanced breast cancer (SERENA-2): a multi-dose, open-label, randomised, phase 2 trial

Cognitions and physical impairments in relation to upper limb function in women with pain and myofascial dysfunctions in the late stage after breast cancer surgery : an exploratory cross-sectional study

Randomized CLIO/BGOG-ov10 trial of olaparib monotherapy versus physician's choice chemotherapy in relapsed ovarian cancer

PIK3CA in breast cancer : a Belgian practical testing guideline

Radical hysterectomy without adjuvant radiotherapy in patients with cervix carcinoma FIGO 2009 IB1, with or without positive Sedlis criteria

The mitotic checkpoint is a targetable vulnerability of carboplatin-resistant triple negative breast cancers

Adherence to and patient satisfaction with the combination therapy of exemestane and everolimus in postmenopausal women with HR+ HER2- advanced breast cancer : results from the IPSOC-mamma study

Cancer surveillance in healthy carriers of germline pathogenic variants in BRCA1/2 : a review of secondary prevention guidelines

Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

Contents

Support

Contact